New Corporate Management Team at Adtec.
Adtec Europe is happy to announce a new President at our parent company Adtec Plasma Technology Co., Ltd Japan (listed on TSE 6668) - Mr Hidenori Morishita. Mr Morishita has been working at Adtec Japan for over 15 years primarily in the role of business development.
Adtec Europe Ltd introduces new Actinic Keratoses Clinical Trial Results at the European Academy of Dermatology and Venerology Annual Meeting in Paris.
P0736 – Efficacy of cold atmospheric plasma versus diclofenac 3% gel in patients with actinic keratoses/field cancerization: preliminary results of a prospective, randomized, rater-blinded study (ACTICAP).
Leeds Teaching Hospitals NHS Trust joins as a trial centre for current RCT
Adtec Healthcare is excited to announce that Leeds Teaching Hospitals NHS Trust will be joining as a trial centre for our randomised controlled trial to evaluate the efficacy of non-thermal gas plasma on sub-clinical wound infection (biofilm) in patients with diabetic foot ulcers compared to those treated with standard care of dressings. The clinical team will be led by our clinical partners, Mr David Russell, the Podiatry and Vascular Research Teams in the Diabetes Limb Salvage Service at Leeds Teaching Hospitals. The Chief Investigator for the trial is Professor Steven Jeffery from HM Forces, Queen Elizabeth Hospital.
Adtec Healthcare to exhibit at EWMA
We are excited to be exhibiting at this year’s EWMA2018 in Krakow May 9th-11th.
You can find us at booth number W114 where we will of course have our SteriPlas medical device on display, ready to give a live demonstration on how a quick 2-minute application is enough to deactivate microrganisms including antibiotic resistant bacteria.
Innovation Award for SteriPlas Plasma Technology.
Adtec Healthcare congratulates Dr Rotering on his receipt of the runner up Innovation award at the European Association for Cardio-Thoracic Surgery (EACTS) conference in Vienna on October 7th 2017..
Adtec receives second place award in the ‘Most Innovative Product’ Category in Journal of Wound Care awards
We are delighted to be awarded second place in the ‘Most Innovative Product:’ category at the Journal of Wound Care/ World Union of Wound Healing Societies awards. The results were announced at the awards ceremony on Tuesday September 27th during the WUWHS congress in Florence.
Adtec Healthcare reports new case studies on the successful treatment of long-term chronic ulcers.
Adtec Healthcare reports the successful wound management of patients with long term chronic ulcers at 2 hospitals in Germany and Switzerland. Some of these results are included in case studies on the website. The patients had been suffering from long term chronic ulcers where all other treatments had failed. Treatment with Adtec SteriPlas gas plasma managed the infection and the ulcers progressed to complete healing. Following these encouraging case studies results, it is necessary to do a randomized controlled clinical trial to prove the clinical efficacy and benefits.
Clinical Trial to investigate the potential benefits of treating Actinic Keratosis with Adtec SteriPlas plasma technology.
Adtec Europe today announces the launch of a clinical trial to evaluate the change of the cutaneous microbiome in correlation to the efficacy of SteriPlas plasma technology compared to standard treatments on patients with Actinic Keratosis.
Adtec Europe will exhibit at two events in 2017 showcasing our atmospheric pressure gas plasma technology for surface treatment applications in precision engineering.
Potential applications of plasma treatment include
- Surface cleaning
- Surface modification
- Surface Activation
- Removal of organic contamination
Adtec introduces the plasma product portfolio designed and manufactured in the UK by Adtec Europe Limited
Plasma processing is a material processing technology that is utilized to modify the chemical and physical properties of a surface. Plasma processing is most often in vacuum plasma chambers widely used in the semiconductor and display industries to meet the critical engineering requirements of high-tech industries.